• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Chest CTA/leg CT combo affords better PE detection

Article

A multicenter study funded by the National Heart, Lung, and Blood Institute says that combining a CT scan of the legs with chest CT angiography increases the chances of detecting pulmonary embolism.

A multicenter study funded by the National Heart, Lung, and Blood Institute says that combining a CT scan of the legs with chest CT angiography increases the chances of detecting pulmonary embolism.

Researchers from eight clinical centers compared three ways to diagnose blood clots in 824 patients suspected of having PE: chest CT angiography alone, chest CTA with venous-phase imaging (leg CT), and chest CTA with an objective clinical assessment known as the Wells Score. The combined chest CTA and leg CT approach provided PE detection and specificity rates of 90% and 95%, respectively. A high clinical probability combined with positive chest CTA correctly indicated PE in 96% of participants. However, a negative chest CTA on these patients did not confidently rule out PE.

The study appeared in the June 1 issue of the New England Journal of Medicine.

Recent Videos
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, Part 1
Addressing Cybersecurity Issues in Radiology
Computed Tomography Study Shows Emergence of Silicosis in Engineered Stone Countertop Workers
Can an Emerging AI Software for DBT Help Reduce Disparities in Breast Cancer Screening?
Skeletal Muscle Loss and Dementia: What Emerging MRI Research Reveals
Magnetoencephalopathy Study Suggests Link Between Concussions and Slower Aperiodic Activity in Adolescent Football Players
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Assessing a Landmark Change in CMS Reimbursement for Diagnostic Radiopharmaceuticals
Addressing the Early Impact of National Breast Density Notification for Mammography Reports
2 KOLs are featured in this series.
Related Content
© 2024 MJH Life Sciences

All rights reserved.